McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726.
Kumar L, Mahla H, Chaturvedi N, Sharma SM, Bagarhatta R. Prediction of mortality using Get With The Guidelines Heart Failure score (GWTG-HF), its comparison with APACHE II score, and its correlation with NT-proBNP levels: a study among patients with acute decompensated heart failure in the Southeast Asian region. medRxiv. 2023:23290079.
Feng J, Zhang Y, Zhang J. Epidemiology and burden of heart failure in Asia. JACC Asia. 2024;4:249-64.
Harmadha WSP, Muharram FR, Gaspar RS, Azimuth Z, Sulistya HA, Firmansyah F, et al. Explaining the increase in incidence and mortality of cardiovascular disease in Indonesia: a global burden of disease study analysis (2000–2019). PLoS One. 2023;18(12):e0296857.
Tarigan S, Hasan H, Lubis AC, Mukhtar Z, Haykal B, Sarastri Y. Correlation of MAGGIC Score with major adverse cardiac events in patients with chronic heart failure at H. Adam Malik Medan Hospital. Int J Res Stud Med Health Sci. 2021;8(10).
Moltó-Balado P, Reverté-Villarroya S, Monclús-Arasa C, Balado-Albiol MT, Baset-Martínez S, Carot-Domenech J, et al. Heart failure and major adverse cardiovascular events in patients with atrial fibrillation: a retrospective primary care cohort study. Biomedicines. 2023;11(7):1825.
Nasution SA, Perkasa H, Ginanjar E, Rinaldi I. In-hospital major adverse cardiac events factor predictors of ST-elevation myocardial infarction after primary percutaneous coronary intervention at dr. Cipto Mangunkusumo General Hospital. eJKI. 2022;10(2):133-41.
Ilyas KK, Kasiman S, Hasan H, Mukhtar Z, Hasan R, Raynaldo AH. Acta Cardiologia Indonesiana heart score for predicting in-hospital major cardiovascular event in patients with non-ST segment elevation acute coronary syndrome. Acta Cardiol Indones. 2020;6(2):77-85.
Ahmad FB, Anderson RN. The leading causes of death in the US in 2020. JAMA. 2021;325(18):1829-30.
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology. Cardiovascular disease statistics, 2021. Eur Heart J. 2022;43(8):716-99.
Arsyad DS, Westerink J, Cramer MJ, Ansar J, Wahiduddin, Visseren FLJ, et al. Modifiable risk factors in adults with and without prior cardiovascular disease: Findings from the Indonesian National Basic Health Research. BMC Public Health. 2022;22(1):2286.
American Heart Association. Get With The Guidelines – Heart Failure. Dallas, TX: AHA; 2021.
Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association ’sGet With the Guidelines Program. Circ Cardiovasc Qual Outcomes. 2010;3(1):25-32.
Lyle M, Wan SH, Murphree D, Bennett C, Wiley BM, Barsness G, et al. Predictive value of the Get With The Guidelines-Heart Failure risk score in unselected cardiac intensive care unit patients. J Am Heart Assoc. 2020;9(3):e012439.
Suzuki S, Yoshihisa A, Sato Y, Kanno Y, Watanabe S, Abe S, et al. Clinical significance of the Get With The Guidelines-Heart Failure risk score in patients with chronic heart failure after hospitalization. J Am Heart Assoc. 2018;7(17):e008316.
Shiraishi Y, Kohsaka S, Abe T, Mizuno A, Goda A, Izumi Y, et al. Validation of the Get With The Guidelines–Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level. Am Heart J. 2016;171(1):33-39.
Qian F, Fonarow GC, Krim SR, Vivo RP, Cox M, Hannan EL, et al. Characteristics, quality of care, and in-hospital outcomes of Asian-American patients with heart failure: findings from the American Heart Association Get With The Guidelines–Heart Failure Program. Int J Cardiol. 2015;189:141-7.
Kumar L, Mahla H, Chaturvedi N, Sharma SM, Bagarhatta R. Prediction of mortality using Get With The Guidelines Heart Failure score (GWTG-HF), its comparison with APACHE II score and its correlation with NT-proBNP levels: a study among patients of Acute Decompensated Heart Failure from South East Asian region. medRxiv [preprint]. 2023:2023.05.16.23290079.
Iliadis C, Spieker M, Kavsur R, Metze C, Hellmich M, Horn P, et al. Get with the Guidelines Heart Failure Risk Score for mortality prediction in patients undergoing MitraClip placement Clin Res Cardiol. 2021;110(12):1871-80.
Bo X, Zhang Y, Liu Y, Kharbuja N, Chen L. Performance of the heart failure risk scores in predicting 1-year mortality and short-term readmission of patients. ESC Heart Fail. 2023;10(1):502-17.
Mahmood M, Banerjee SK. Prediction of in-hospital mortality using Get With The Guidelines-Heart Failure (GWTG-HF) risk scores in patients hospitalized with heart failure. Eur Heart J. 2022;43(Suppl 1).
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-1032.
Schwinger RHG. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021;11(1):263-76.
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139-596.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795-808.
Abassi Z, Khoury EE, Karram T, Aronson D. Edema formation in congestive heart failure and the underlying mechanisms. Front Cardiovasc Med. 2022;9:933215.
Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2018.
Obokata M, Reddy YNV, Borlaug BA. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms using noninvasive methods. JACC Cardiovasc. 2020;13(1 Pt 2):245-57.
Abimanyu R, Sitepu A, Nasution AN. Comparison of Syntax II and Grace scores as predictors of major cardiovascular events 30 days after treatment in STEMI patients undergoing PPCI. J Soc Med. 2024;3(6):171-7.
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society, and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23(3):352-80.
Riccardi M, Sammartino AM, Piepoli M, Adamo M, Pagnesi M, Rosano G, et al. Heart failure: an update from the last years and a look at the near future. ESC Heart Fail. 2022;9(6):3667-93.
Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241.
Rocha H, Gouveia R, Elias C, Reis C, Fonseca AM, Costa A, et al. Systolic blood pressure increase in chronic heart failure is associated with survival advantage. Porto Biomed J. 2025;10(2):e284.
Böhm M, Bewarder Y, Kindermann I, Slawik J, Wintrich J, Werner C. Optimization of heart failure treatment by heart rate reduction. Int J Heart Fail. 2019;2(1):1-11.
Duan S, Li Y, Yang P. Predictive value of blood urea nitrogen in heart failure: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1189884.
World Health Organization (WHO). World Report on Ageing and Health. Geneva: World Health Organization; 2015.
Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34(19):1404-13.
Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572-80.
Chioncel O, Mebazea A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical phenotypes and outcomes of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(10):1242-54.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol. 2017;70(6):776-803.
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995-2008.
Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020;396(10254):819-829.
Greene SJ, Butler J, Fonarow GC. Contextualizing risk among patients with heart failure. JAMA. 2021;326(22):2261-2.
Damman K, Tang WHW, Felker GM, Lassus J, Zannad F, Krum H, et al. Current evidence on the treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol. 2014;63(9):853-71.
Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476-86.
Tanai E, Frantz S. Inflammatory markers in heart failure. Heart Fail Rev. 2021;26(2):201-10.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes of empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-24.
Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: Mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(1):16-37.
Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217-26.
Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, et al. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol. 2017;69(24):2885-96.
Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcomes in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35(7):455-69.
Peterson PN, Magid DJ, Lyons EE, Clarke CL, Zeng C, Albert NM, et al. Association of Get With The Guidelines-Heart Failure Program with improved outcomes. Circ Heart Fail. 2010;3(6):682-9.
Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade M. The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol. 2015;12(4):220-9.
Schrage B, Uijl A, Benson L, Westermann D, Stolfo D, Dahlström U, et al. Temporal trends in cardiogenic shock complicated by acute myocardial infarction. Eur Heart J. 2022;43(5):453-64.
Stehlik J, Edwards LB, Rowe A, Stevenson LW, Mehra MR, Lindenfeld J, et al. Sudden cardiac death in heart failure: contemporary risk predictors and prevention. Eur Heart J. 2020;41(2):199-208.
Kotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JC, et al. Effect of digoxin vs bisoprolol on heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA. 2020;324(24):2498-508.
Cowie MR, Lopatin YM, Saldarriaga C, Fonseca C, Sim D, Magaña JA, et al. The Optimize Heart Failure Care Program: Initial lessons from global implementation. Int J Cardiol. 2017;239:1-6.
Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA. Cost-effectiveness of heart failure therapy Nat Rev Cardiol. 2013;10(6):338-54.
Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical phenotypes and outcomes of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(10):1242-54.
Tan LB, Williams SG, Tan DK, Cohen-Solal A, et al. Admission systolic blood pressure and prognosis in acute decompensated heart failure. Eur J Heart Fail. 2020;22(12):2298-308.
Zhang Y, Zhang J, Butler J, Yang X, Xie P, Guo D, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China heart failure (China-HF) registry. J Card Fail. 2017;23(12):868-75.
Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. The use of diuretics in heart failure with congestion: A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(2):137-55.